Skip to main content

TRANSCAT INC. Value Stock - Dividend - Research Selection


ISIN: US8935291075, WKN: 923106

Market price date: 04.06.2021
Market price: 55,90 USD

TRANSCAT INC. Fundamental data and company key figures of the share

Annual reports in USD
Key figures 26-05-2021
Cash flow
Net operating cash flow 23.639.000
Capital Expenditures -6.617.000
Free cash flow 17.022.000
Balance sheet
Total Equity 75.078.000
Liabilities & Shareholders equity 132.116.000
Income statement
Net income 7.791.000
Eps (diluted) 1,030
Diluted shares outstanding 7.458.250
Net sales/revenue 173.335.000

Fundamental ratios calculated on: 04-06-2021

Key figures 04-06-2021
Cash flow
P/C 17,64
P/FC 24,49
Balance sheet
Income statement
Div. Yield0,00%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization416.916.160,00 USD
IndicesNASDAQ Comp.
Raw Data SourceUS GAAP in Millionen USD
Stock Split1997-07-24,2.0000/1.0000; 1997-07-23,2.0000/1.0000; 1982-08-03,2.0000/1.0000; 1981-08-04,2.0000/1.0000

Description of the company

Transcat, Inc. is a provider of calibration, repair, inspection and compliance services and distributor of professional grade handheld test, measurement and control instrumentation. The Company operates in two segments: Service and Distribution. The Company´s Service segment also offers compliance services, which include remediation, validation and analytical services primarily to pharmaceutical and FDA-regulated customers. Through its Distribution segment, the Company markets and sells national and brand instruments to approximately 15,000 customers. The Company provides products and services to pharmaceutical industry and FDA-regulated businesses, such as biotechnology and medical device manufacturing; industrial manufacturing companies; energy industry and power, natural gas and water utility companies; chemical process industry, and other industries which require accuracy in their processes and confirmation of the capabilities of their equipment.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,